Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,290,642 papers from all fields of science
Search
Sign In
Create Free Account
CTCFL gene
Known as:
BROTHER OF THE REGULATOR OF IMPRINTED SITES
, CCCTC-BINDING FACTOR-LIKE PROTEIN
, cancer/testis antigen 27
Expand
This gene plays a role in gene regulation.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
CTCFL protein, human
Transcriptional Regulation
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Corrigendum: Testis-specific transcriptional regulators selectively occupy BORIS-bound CTCF target regions in mouse male germ cells
Samuel Rivero-Hinojosa
,
S. Kang
,
Victor V Lobanenkov
,
G. Zentner
Scientific Reports
2017
Corpus ID: 29912419
Scientific Reports 7: Article number: 41279; published online: 01 February 2017; updated: 04 August 2017. In the original version…
Expand
Highly Cited
2013
Highly Cited
2013
The cancer‐testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells
Jessamy Tiffen
,
C. Bailey
,
+6 authors
J. Rasko
International Journal of Cancer
2013
Corpus ID: 22487996
BORIS and CTCF are paralogous, multivalent 11‐zinc finger transcription factors that play important roles in organizing higher…
Expand
2012
2012
Cancer‐testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer
K. Okabayashi
,
T. Fujita
,
+11 authors
Y. Kawakami
Cancer Science
2012
Corpus ID: 23322726
Esophageal squamous cell cancer (ESCC) is one of the most common lethal tumors in the world, and development of new diagnostic…
Expand
2011
2011
ARH cooperates with AP-1B in the exocytosis of LDLR in polarized epithelial cells
Richard S. Kang
,
H. Fölsch
Journal of Cell Biology
2011
Corpus ID: 6097075
The low-density lipoprotein receptor (LDLR) doesn’t directly bind AP-1B; however, it relies on this clathrin adaptor for…
Expand
2011
2011
Cancer-testis antigen, BORIS based vaccine delivered by dendritic cells is extremely effective against a very aggressive and highly metastatic mouse mammary carcinoma.
M. Mkrtichyan
,
A. Ghochikyan
,
+7 authors
M. Agadjanyan
Cellular Immunology
2011
Corpus ID: 2218268
2011
2011
Widespread Expression of BORIS/CTCFL in Normal and Cancer Cells
T. Jones
,
B. Ogunkolade
,
+5 authors
D. Sheer
PLoS ONE
2011
Corpus ID: 17595728
BORIS (CTCFL) is the paralog of CTCF (CCCTC-binding factor; NM_006565), a ubiquitously expressed DNA-binding protein with diverse…
Expand
2010
2010
Molecular architecture of CTCFL.
Amy E. Campbell
,
Selena Martinez
,
J. Miranda
Biochemical and Biophysical Research…
2010
Corpus ID: 10218028
Highly Cited
2009
Highly Cited
2009
Coordinated Activation of Candidate Proto-Oncogenes and Cancer Testes Antigens via Promoter Demethylation in Head and Neck Cancer and Lung Cancer
I. Smith
,
Chad A. Glazer
,
+14 authors
J. Califano
PLoS ONE
2009
Corpus ID: 2363784
Background Epigenetic alterations have been implicated in the pathogenesis of solid tumors, however, proto-oncogenes activated by…
Expand
2008
2008
Selective apoptosis of breast cancer cells by siRNA targeting of BORIS.
C. Dougherty
,
T. Ichim
,
+5 authors
Boris N. Reznik
Biochemical and Biophysical Research…
2008
Corpus ID: 5229661
2006
2006
Antitumor efficacy of DNA vaccination to the epigenetically acting tumor promoting transcription factor BORIS and CD80 molecular adjuvant
D. Loukinov
,
A. Ghochikyan
,
+4 authors
M. Agadjanyan
Journal of Cellular Biochemistry
2006
Corpus ID: 46467208
Cancer testis (CT) antigens are promising candidates for tumor vaccines due to their immunogenicity and tissue‐restricted…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE